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Lymphocytes lacking the TRPM7 (transient receptor
potential cation channel, subfamily M, member 7)
dual function ion channel/protein kinase exhibit
a unique phenotype: they are unable to proliferate
in regular media, but proliferate normally in media
supplemented with 10–15 mM extracellular Mg2+.
Here, we have analyzed the molecular mechanisms
underlying this phenotype. We find that upon transi-
tion from proliferation-supporting Mg2+-supple-
mented media to regular media, TRPM7-deficient
cells rapidly downregulate their rate of growth, re-
sulting in a secondary arrest in proliferation. The
downregulated growth rate of transitioning cells is
associated with a deactivation of signaling down-
stream from phosphoinositide 3-kinase, and expres-
sion of constitutively active p110 phosphoinositide
3-kinase is sufficient to support growth and prolifer-
ation of TRPM7-deficient cells in regular media.
Together, these observations indicate that TRPM7
channels are required for sustained phosphoinosi-
tide 3-kinase-dependent growth signaling and there-
fore, that TRPM7 is positioned alongside phos-
phoinositide 3-kinases as a central regulator of
lymphocyte growth and proliferation.
INTRODUCTION
TRPM7 (transient receptor potential cation channel, subfamily
M, member 7) is a novel dual function protein that possesses
both ion channel and protein kinase domains. TRPM7-channel
function has been shown to be responsive to multiple recep-
tor-mediated inputs (reviewed in Schmitz et al., 2007), and stud-
ies from our laboratory have shown that TRPM7-deficient cells
fail to proliferate in normal tissue-culture media (Schmitz et al.,
2003), suggesting a role for TRPM7-channel function in regula-
tion of cell proliferation. Remarkably, TRPM7-deficient cells are
able to proliferate normally when placed in media with 10–15
mM supplemental extracellular Mg2+ (physiological [Mg2+]ex =
0.4 mM). In conjunction with the observation that humans
deficient in TRPM6, a close TRPM7 homolog predominantly
expressed in the kidney, exhibit a specific defect in renal Mg2+84 Cell Metabolism 8, 84–93, July 2008 ª2008 Elsevier Inc.uptake, complementation of the TRPM7-deficient proliferative-
arrest phenotype by supplemental extracellular Mg2+ or heterol-
ogous Mg2+-transporter expression has led to the proposal that
TRPM7 is involved in regulating Mg2+ uptake required for cell
proliferation (Sahni et al., 2007; Schmitz et al., 2004, 2003). How-
ever, the molecular mechanisms leading to the proliferative
arrest of TRPM7-deficient cells and how these events are related
to cellular Mg2+ uptake have remained undefined.
To gain further insight into TRPM7’s role in supporting prolifer-
ation, we analyzed TRPM7-deficient lymphocytes during their
transition to proliferative arrest in regular tissue-culture media.
Cell-cycle analyses showed that TRPM7-deficient cells cultured
in regular media accumulate in the G0/G1 and early G2 phases of
the cell cycle, suggesting that their proliferative arrest is due to a
primary failure of cell growth (increase in size and mass), as
opposed to a failure of DNA synthesis or mitosis. Biochemical
and genetic analyses demonstrated that the growth failure of
TRPM7-deficient cells cultured in regular media is due to
a lack of sustained activation of phosphoinositide 3-kinase-
dependent signaling, including growth regulatory signaling along
the mTORC1 (mammalian target of rapamycin complex 1) path-
way. Overall, our results suggest that TRPM7 regulates lympho-
cyte growth through a requirement of its channel function for
sustained activation of phosphoinositide 3-kinase growth regu-
latory pathways.
RESULTS
TRPM7-Deficient Cells Fail to Grow
Inhibition of the proliferation of tumor cells in culture may be
induced by compromise of biosynthetic metabolism, inhibition
of DNA synthesis, DNA damage, or inhibition of mitosis. These
mechanisms are distinguishable through analysis of DNA
content and cell size (reviewed in Cooper, 2004). To determine
which of these mechanisms contribute to the proliferative arrest
of TRPM7-deficient cells cultured in regular media, we analyzed
the DNA content (via DAPI [40-6-diamidino-2-phenylindole] stain-
ing) and cell size (via forward scatter) of TRPM7-deficient cells
upon transition from proliferation in growth-supporting Mg2+-
supplemented media to regular media (Figure 1A). After 24 hr
in regular media, TRPM7-deficient cells displayed a striking
accumulation of cells in the G0/G1 phase of the cell cycle (left
panel), as well as a reduction in average cell size (middle panel).
Furthermore, comparison of the size of WT cells and TRPM7-
deficient cells with 2n or 4n DNA content indicated that TRPM7-
deficient cells arrested in G0/G1 (2n content) are smaller than
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TRPM7 Supports Sustained PI3K SignalingFigure 1. Proliferative Arrest of TRPM7-Deficient Cells in Regular Media Is Due to Primary Failure of an Endogenous Growth Regulatory
Mechanism
(A) Proliferative arrest of TRPM7-deficient cells is associated with reduced average cell size and accumulation of cells in the G0/G1 cell-cycle phase. Left panel:
DNA-content analysis of cell-cycle distribution of WT and TRPM7-deficient cells after 24 hr of culture in regular tissue-culture media () or regular media sup-
plemented with 15 mM Mg2+ (+) is shown. Middle panel: forward-scatter analysis of cell-size distribution of DT40 WT and TRPM7-deficient cells after the indi-
cated periods of culture in regular tissue-culture media () or regular media supplemented with 15 mM Mg2+ (+) is shown. Right panel: forward-scatter analysis of
cell-size distribution of TRPM7-deficient cells with 2n or 4n DNA content after the indicated periods of culture in regular tissue-culture media () is shown.
(B) WT DT40 cells cultured under conditions in which Mg2+ uptake is specifically compromised exhibit reduced cell size and G0/G1 cell-cycle accumulation. Left
panel: DNA-content analysis of cell-cycle distribution of WT DT40 cells after 24 hr of culture in depolarizing tissue-culture media with the indicated amounts of
added Mg2+ (as MgCl2) is shown. Right panel: forward-scatter analysis of cell-size distribution of WT DT40 cells after 24 hr of culture in depolarizing tissue-culture
media with the indicated amounts of added Mg2+ (as MgCl2) is shown. All results are representative of three separate experiments.those arrested in G2 (4n content); and that G2-arrested TRPM7-
deficient cells are smaller than a significant fraction of WT cells,
consistent with an arrest in cell growth occurring at a cell’s rela-
tive cell-cycle position at the time of transition (right panel).
Taken together, these results indicate that TRPM7-deficient cells
undergo a failure of growth (i.e., increase in size and mass) as
opposed to primary failure or compromise of DNA replication,
DNA damage, or mitosis—in conjunction with their proliferative
arrest in standard cell-culture conditions.
As our TRPM7-deficient cells were generated via gene target-
ing in the presence of media with supplemental Mg2+, it is possi-
ble that their growth failure reflects a nonphysiological response
to the decreased extracellular Mg2+ concentrations present in
standard tissue-culture media. To evaluate WT DT40 cells’ re-
sponse to limitation of Mg2+ uptake, we placed WT DT40 cells
into culture conditions in which both electrical (membrane
potential) and chemical (concentration gradient) forces for
Mg2+ entry were compromised (Figure 1B). In these experi-ments, WT DT40 cells were placed in Mg2+-free tissue-culture
media in which 95 mM NaCl was replaced with 95 mM KCl,
thereby substantially reducing their membrane potential (this
media is designated as depolarizing media or DP), and with vary-
ing amounts of added Mg2+ (as MgCl2). After 24 hr in these
conditions, cell cycle and size were analyzed as in Figure 1B.
As can be seen, WT DT40 cells are able to proliferate normally
and exhibit a normal cell size when grown in depolarizing media
with 0.4 mM MgCl2 added (the same amount present in typical
RPMI-1640 tissue culture media): thus, the reduced membrane
potential achieved by the depolarizing media does not compro-
mise nutrient uptake to a point that growth is affected. However,
as extracellular Mg2+ is progressively decreased, the WT DT40
cells undergo a similar type of growth arrest to that observed
in the TRPM7-deficient cells grown in regular media, with accu-
mulation of cells in G0/G1 and G2 (left panel) along with a progres-
sive reduction in average cell size (right panel). Furthermore,
cells with 2n had smaller sizes than those with 4n DNA content,Cell Metabolism 8, 84–93, July 2008 ª2008 Elsevier Inc. 85
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TRPM7 Supports Sustained PI3K SignalingFigure 2. Growth Arrest of TRPM7-Deficient Cells Correlates with Failure of Growth Regulatory Signaling above the Level of mTOR Protein
Kinase
(A) Growth arrest of TRPM7-deficient and WT DT40 cells correlates with deactivation of the growth-regulator effector ribosomal S6 kinase (S6K1). Upper-left
panel: TRPM7-KO cells were washed twice with PBS and transferred to fresh media with supplemental Mg2+ for 2 hr, following which the cells were washed
and transferred to regular media without () or with (+) supplemental Mg2+ and analyzed for p-S6Kl (Thr389) activation. Cells pretreated with 100 nM rapamycin
(Rap) displayed a significant reduction in p-S6Kl. S6K1 showed a detectable decrease in phosphorylation by 3 hr in regular media alone and was substantially
downregulated by 5 hr. Upper-middle panel: TRPM7-KO cells were transferred to fresh media without any supplemental Mg2+ () for 5 hr before transitioning the
cells to regular media without () or with (+) 15 mM supplemental Mg2+. P-S6K1 (Thr389) showed an increase in activity within 2 hr of transition to (+) media con-
ditions. Upper-right panel: analysis of the fold change in p-S6Kl (Thr389) from three independent experiments is shown. A 4-fold increase was observed by 2 hr,
increasing slightly further to 5-fold by 4 hr, respectively, in cells growing under (+) media conditions versus () media conditions. The graph shows averages plus
standard errors of the means (error bars), and P values for the fold change were calculated using Student’s t test. Changes at 2 hr and 4 hr were found to be highly
statistically significant (p = 0.002 for 2 hr and p = 0.016 for 4 hr). Lower-middle panel: WT DT40 cells were placed in Mg2+ -free depolarizing media for 5 hr, and then
0.4 mM Mg2+ was added back at the indicated times. Alternatively, WT DT40 cells were maintained in regular media for the duration of the experiment as
indicated.
(B) TRPM7-deficient cells exhibit deactivation of the growth regulatory effector 4E-BP1 but not the mitogen-activated kinase p42 ERK. Left panel: activity of phos-
pho-4E-BP1 (Ser65) was slightly increased by 2–4 hr after Mg2+ add-back and was inhibited in presence of 100 nM rapamycin. Right panel: p-Erk (Thr185/Tyr187)
remained unchanged under experimental conditions mentioned above, in absence () or presence (+) of 15 mM supplemental Mg2+ in the growth media. Please
note that the top band observed in the total Erk blot is thought to be nonspecific as DT40 cells only express Erk2 (Roose et al., 2007).
(C) TRPM7-deficient and WT DT40 cells exhibit G0/G1 arrest in response to the mTOR inhibitor rapamycin, which is not reversible via supplemental Mg
2+. Left
panel: rapamycin (100 nM) induces a G1 arrest in DT40 WT cells both in absence () and presence (+) of supplemental Mg2+ at 48 hr. Middle panel: rapamycin
induces a G0/G1 arrest in the TRPM7-KO cells by 48 hr, which is not reversible by supplemental Mg
2+. Right panel: cell-size analysis of DT40 WT and TRPM7-KO
cells in presence of 15 mM Mg2+ and rapamycin is shown. Both DT40 WT cells as well as the TRPM7-KO cells show a reduction in cell size in presence of86 Cell Metabolism 8, 84–93, July 2008 ª2008 Elsevier Inc.
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media (data not shown). Overall, these results indicate that the
growth failure and cell-cycle changes observed in TRPM7-
deficient cells placed in regular media are the result of a cellular
regulatory response to limitation of Mg2+ uptake.
Translational Downregulation in TRPM7-Deficient Cells
Eukaryotic cells have the capacity to adjust their rate of growth in
response to nutrient limitations (amino acids, glucose, etc.) and
growth factors by regulating macromolecular synthesis through
a well-defined biochemical mechanism involving the signaling
complex mTORC1 (reviewed in Wullschleger et al., 2006). As
the failure of cell growth observed in TRPM7-deficient cells re-
sembled that induced by the mTORC1 inhibitor rapamycin, we
assessed the activation status of mTORC1 signaling in transi-
tioning TRPM7-deficient cells by interrogating a key effector in
mTORC1-dependent regulation of cell growth, ribosomal S6 ki-
nase (S6K). S6K, which is expressed in two forms in mammalian
cells (S6K1 and S6K2), regulates ribosomal translation through
phosphorylation of the S6-ribosomal subunit, and is thought to
be a direct downstream target of mTORC1. The activation status
of S6K1 in TRPM7-deficient cells transitioned between growth-
supporting Mg2+-supplemented media and growth-arresting
regular media was assessed using immunoblotting analyses of
the phosphorylation level of Thr389 of S6K1, an established indi-
cator of its activation status (Shah and Hunter, 2004) with or with-
out 100 nM rapamycin. As can be seen in Figure 2A (top-left
panel), S6K1 Thr389 phosphorylation is detectably downregu-
lated by 3 hr posttransfer of TRPM7-deficient cells from
growth-supporting to regular media, and substantially downre-
gulated by 5 hr posttransfer. Similarly, transfer of TRPM7-KO
(knockout) cells cultured for 5 hr in regular media to growth-
supporting conditions resulted in a marked upregulation of
S6K1 phosphorylation, which was significantly detectable by
2 to 4 hr (Figure 2A, top-middle and -right panels). As expected,
rapamycin treatment in both cases inhibited p-S6K1. That this
response reflects a normally operative endogenous regulatory
pathway was evaluated by placing WT DT40 cells in Mg2+-free
depolarizing media and evaluating S6K1 phosphorylation before
and after readdition of Mg2+-WT DT40 cells exhibited a similar
reduction of S6K1 activation over 5 hr exposure to Mg2+-free de-
polarizing media (Figure 2A, bottom panel; compare lane 1 with
lane 5), which was rapidly reversed upon provision of physiolog-
ical amounts of Mg2+ (Figure 2A, bottom panel; compare (+)
to () media in lanes 1–4).
We also evaluated two other proteins implicated in regulation
of cell growth and proliferation: 4E-BP1 (eukaryotic translation
initiation factor 4E binding protein 1), which like S6K1, is thought
to be a major direct target of the mTORC1 complex (Bhaskar and
Hay, 2007); and p42 ERK, a mitogen-activated protein kinase
(MAPK) and an important effector of mitogenic signaling acti-
vated by growth-factor receptors (Dhillon et al., 2007). In
TRPM7-deficient cells cultured for 5 hr in regular media, 4E-
BP1 exhibited slightly reduced Ser65 phosphorylation, as well
as reduced abundance of its active high molecular weight form(see Supplemental Data; Figure S1, right panel, last three lanes).
4E-BP1 also exhibited rephosphorylation of S65 and an in-
creased abundance of its active high molecular weight form after
transfer from regular media to growth-supporting conditions
(Figure 2B, left panel), supporting the hypothesis that mTORC1
growth regulatory signaling is diminished in TRPM7-deficient
cells cultured in regular media. After treatment with rapamycin
(100 nM), phosphorylation of 4E-BP1 was drastically reduced
as expected. We were unable to detect changes in the phos-
phorylation of Erk (Thr185/Tyr187) within a 4 hr time frame after
transition of cells to growth-supporting conditions (Figure 2B,
right panel), consistent with TRPM7-deficient cells continuing
to receive a full complement of mitogenic signaling from the tis-
sue-culture media.
mTORC1 Activation Fails in TRPM7-Deficient Cells
Taken together, the above results indicate that TRPM7-deficient
cells transitioned to regular media undergo a downregulation of
cell growth, which is closely correlated with interruption of
growth signaling to downstream effectors S6K1 and 4E-BP1.
As mentioned above, the mammalian target of rapamycin
(mTOR) protein kinase component of the mTORC1 complex
is thought to directly phosphorylate and activate S6K1 and
4E-BP1, and is highly specifically inhibited by the macrolide
antibiotic rapamycin. To establish whether TRPM7-dependent
regulation of S6K1 and 4E-BP1 occurs at or above the level of
mTORC1, we treated WT and TRPM7-KO cells with 100 nM ra-
pamycin, cultured them in regular media or Mg2+-supplemented
growth-supporting media, and analyzed their cell-cycle distribu-
tion and cell size (Figure 2C). As seen in Figure 2C, left panel,
rapamycin induced an accumulation of WT DT40 cells in G0/G1
by 48 hr, but the observed accumulation was not reversed
upon culturing the WT DT40 cells in growth-supporting media
with supplemental Mg2+. A 48 hr treatment with rapamycin
induced a similarly significant accumulation in G0/G1 of
TRPM7-deficient cells grown in growth-supporting media with
supplemental Mg2+ (Figure 2C, middle panel), and led to a reduc-
tion in cell size of both WT DT40 and TRPM7-deficient DT40 cells
(Figure 2C, right panel). Culture in growth-supporting Mg2+-sup-
plemented media was also not able to prevent the rapamycin-in-
duced reduction in cell size in either TRPM7-KO or wild-type
cells (Figure 2C, right panel). Overall, the lack of ability of Mg2+
supplementation to reverse the effects of rapamycin in WT or
TRPM7-deficient DT40 cells indicates that the downregulation
of growth regulatory signaling, which occurs when TRPM7-KO
DT40 cells are cultured in regular media, is caused by an inter-
ruption of growth regulatory signaling at or above the level
of mTORC1.
TRPM7-Deficient Cells Do Not Sustain Akt Activation
The mTORC1 growth regulatory complex is regulated by up-
stream signals from growth-factor receptors and nutrient-sens-
ing pathways relayed through the membrane-proximal effectors
Akt and phosphoinositide 3-kinase (Bhaskar and Hay, 2007).
In order to understand whether signals upstream of mTORC1rapamycin and 15 mM supplemental Mg2+, which is comparable to the cell size of TRPM7-KO cells growing in normal medium with 0.4 mM Mg2+. All data are
representative of three independent experiments.Cell Metabolism 8, 84–93, July 2008 ª2008 Elsevier Inc. 87
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TRPM7 Supports Sustained PI3K SignalingFigure 3. Growth Arrest of TRPM7-Deficient Cells in Regular Media Correlates with Failure of Sustained Akt Activation
(A) Growth arrest of TRPM7-deficient cells in regular media correlates with failure of Akt activation. Top-left panel: immunoblotting analysis of Ser473 phosphor-
ylation of Akt after transition of TRPM7-deficient cells from regular media () to the presence of supplemental Mg2+ (+) is shown. TRPM7-deficient cells were
placed in regular media for 5 hr and continued in those conditions (), or 15 mM supplemental Mg2+ were added (+) for the indicated period of times, followed
by cell lysis, SDS-PAGE, and western immunoblotting analysis of Ser473 phosphorylation. Data are representative of two independent experiments. Lower-left
panel: western immunoblot analysis of Thr308 phosphorylation of Akt in an identical single experiment is shown. Right panel: a comparative phospho-Akt (S473)
analysis between DT40 WT- and TRPM7-deficient cells under optimal growth conditions (+) and regular media () at 4 hr is shown. Data from one of three
independent experiments are shown.
(B) Insulin stimulation of TRPM7-deficient cells induces transient Akt activation in regular media. Left panel: immunoblotting analysis of Ser473 phosphorylation of
Akt in response to transition from regular media () to Mg2+-supplemented media (+) or in response to insulin stimulation of WT DT40 cells is shown. WT DT40
cells were placed in regular media () for 2 hr, and then maintained in that media (), or 15 mM supplemental Mg2+ (+) or 100 nM insulin were added for the in-
dicated period of time. Cells were then lysed and analyzed by SDS-PAGE and western immunoblotting for changes in Akt Ser473 phosphorylation. Right panel:
immunoblotting analysis of Ser473 phosphorylation of Akt after insulin stimulation of TRPM7-deficient cells in regular () or growth-supporting Mg2+-supple-
mented media (+) is shown. TRPM7-deficient cells were placed in regular media for 5 hr, and then maintained in that media with 100 nM insulin () or media
with 100 nM insulin and 15 mM supplemental Mg2+ (+) for the indicated period of time. Cells were then lysed and analyzed by SDS-PAGE and western immu-
noblotting for changes in Akt Ser473 phosphorylation. These results are representative of two independent experiments.are influenced when TRPM7-deficient cells are transitioned to
regular media, we assessed the activation of Akt using a similar
approach to that described earlier for S6K1: cells were transi-
tioned to regular media for 5 hr, followed by a retransition back
to growth-supporting Mg2+-supplemented media (time of re-
transition = time 0 for these experiments). The activation state
of Akt was then assessed by immunoblotting with phosphospe-
cific antibodies to Ser473 and Thr308, phosphorylation of which
has been implicated in Akt activation (Woodgett, 2005). Analo-
gous to p-S6K1, phosphorylation of Akt (Ser473) was substan-
tially reduced in TRPM7-deficient cells cultured for 5 hr in regular
media (Figure S2, right panel). Similarly, phosphorylation of two
sites implicated in Akt activation—Ser473 and Thr308—were
detectably augmented as early as 1 hr after transition back to
growth-supporting media, indicating that mTORC1 deactivation
in TRPM7-deficient cells is at least in part due to a failure of
growth factor and nutrient signals relayed through Akt
(Figure 3A, left and middle panels). Rapamycin treatment did
not have an inhibitory effect on Akt phosphorylation (see indi-
cated lanes in both panels), consistent with Akt’s proposed
position upstream from mTORC1 in the mTORC1 growth regula-
tory signaling pathway. A comparative phospho-Akt (S473) anal-
ysis between DT40 WT and TRPM7-deficient cells under optimal
growth conditions showed similar levels of phosphorylation at88 Cell Metabolism 8, 84–93, July 2008 ª2008 Elsevier Inc.4 hr (Figure 3A, right panel), demonstrating that the observed
changes are not due to idiosyncratic differences in Akt levels
or activation between the cell lines.
A potential explanation for the above results is that growth
factors, such as insulin, are simply unable to activate Akt in
the TRPM7-deficient cells grown in regular medium. To evalu-
ate this possibility, we analyzed insulin-dependent Akt activa-
tion (as assessed by Ser473 phosphorylation, e.g., see Pogue
et al., [2000]). In WT DT40 cells, starting from an already signif-
icant basal level, Akt phosphorylation is not influenced by the
presence of supplemental Mg2+, but addition of 100 nM insulin
generates a readily detectable increase at 1 hr postaddition
(Figure 3B, left panel). In contrast, for TRPM7-deficient cells,
at 1 hr poststimulation, Akt phosphorylation is comparably en-
hanced by either supplemental Mg2+ or the addition of 100
nM insulin (Figure 3B, right panel). However, Akt activation de-
cays back to its time 0 baseline by 2 hr in insulin-stimulated
TRPM7-deficient cells cultured in regular media. That insulin
affects other aspects of the insulin-receptor signaling pathway
equivalently in the two cell types was confirmed by the observa-
tion of identical insulin-induced downregulation of surface insu-
lin receptors by western blotting (Figure S2, left panel). Thus,
TRPM7-deficient cells grown in regular media are competent
for transducing acute Akt-activating signals from growth factors
Cell Metabolism
TRPM7 Supports Sustained PI3K Signalingsuch as insulin, yet are unable to maintain sustained Akt phos-
phorylation.
Constitutive PI3K Supports TRPM7-Independent
Growth
The above results suggest a potential causal role for deficient,
sustained Akt activation in the failure of TRPM7-deficient cells
to grow in regular media. To determine whether a heterologous
signal providing sustained Akt activation could drive TRPM7-
deficient cells to proliferate in regular media, we generated
a doxycycline-regulated construct expressing myristoylated
Akt (myr-Akt) lacking a PH (pleckstrin homology) domain. How-
ever, while we observed complete biochemical complementa-
tion at the level of Akt and S6K1 activation, myr-Akt was not
able to support proliferation of TRPM7-deficient cells (see
Figure S3).
The failure of sustained Akt activation observed in TRPM7-
deficient cells cultured in regular media in conjunction with an
inability of constitutive Akt signaling to support growth of
TRPM7-deficient cells in regular media suggests that TRPM7-
deficiency leads to failure of growth and proliferation secondary
to interruption of sustained signaling along both Akt-dependent
and -independent growth regulatory pathways. As phosphoino-
sitide 3-kinases are major upstream regulators of Akt and related
kinases and are known to activate both Akt-dependent and -in-
dependent growth regulatory pathways (Hawkins et al., 2006), as
well as exit from G0 and progression through G1/S and G2/M
transitions (Dangi et al., 2003; Shtivelman et al., 2002), we next
examined whether provision of a heterologous sustained PI3K
signal could complement the failure of TRPM7-deficient cells
to grow and proliferate in regular media. To provide a sustained
PI3K signal, we utilized a constitutively active myristoylated form
of p110a, catalytic subunit of PI3K (myr-p110), which has been
previously used successfully to identify direct downstream tar-
gets of PI3Ks and has greatly facilitated the analysis of signaling
events regulated by PI3Ks (Auger et al., 2000; Didichenko et al.,
1996; Klippel et al., 1996). TRPM7-deficient cell lines were gen-
erated with doxycycline-inducible expression of myr-p110, and
a clone with undetectable basal and easily detectable induced
expression was chosen for further analysis (Figure 4A, left panel).
Induction of myr-p110 in this cell line generated a clearly detect-
able enhancement of Akt activation in both regular and growth-
supporting media, demonstrating that the induced myr-p110
was expressed at a sufficient level and was appropriately acti-
vating downstream effectors (Figure 4A, right panel). When
myr-p110-expressing TRPM7-deficient cells were placed under
long-term culture in regular media, they exhibited obvious differ-
ences in growth and proliferation relative to uninduced cells
(Figure 4B). A comparative cell-cycle analysis of myr-p110-ex-
pressing cells at approximately 10 days postinduction showed
a clear shift of cells into the S phase relative to those that were
not induced, although not to the degree observed in myr-p110
TRPM7-deficient cells cultured in growth-supporting media
with or without doxycycline (Figure 4B, left panel). Myr-p110 ex-
pression at 10 days postinduction also allowed TRPM7-deficient
cells cultured in regular media to retain their normal size (equiv-
alent to that of WT DT40 cells), and increased the size of TRPM7-
deficient cells cultured in growth-supporting Mg2+-supple-
mented media to supranormal levels (Figure 4B, right panel), di-rectly demonstrating the capacity of the myr-p110 to restore
failed-growth signaling in TRPM7-deficient cells. Furthermore,
the proliferation rate of TRPM7-deficient cells expressing myr-
p110 was observed to increase over time in culture, and a subse-
quent analysis of these cells at 18 days postinduction showed
that, relative to 48 hr induction, induced cells had accumulated
a much higher level of myr-p110 (Figure 4C, left panel), exhibited
a correspondingly greater shift of cells out of G0/G1 into S, and
sustained proliferation (Figure 4C, right panel). These results
suggest that myr-p110 provides a dose-dependent enhance-
ment of growth signaling in TRPM7-deficient cells that are se-
lected for by culture in regular media. This possibility was directly
evaluated by analysis of Akt and S6K1 phosphorylation in
TRPM7-deficient cells cultured in regular media after >18 days
in culture, which demonstrated that the enhanced myr-p110 ex-
pression at this time point sustained full activation of Akt (Fig-
ure 4D, left panel) and nearly full activation of S6K1 (Figure 4D,
right panel). Treatment of cells with wortmannin (Figure 4D), a
PI3K inhibitor, resulted in a significant reduction in the phosphor-
ylation levels of Akt and S6K1, demonstrating their continued
dependence on phosphoinositide 3-kinase signals.
DISCUSSION
We have used cell physiological, biochemical, and genetic com-
plementation assays to gain insight into the unique Mg2+-depen-
dent proliferative-arrest phenotype observed in TRPM7-defi-
cient cells. We find that (1) TRPM7-deficient cells cultured in
regular media exhibit a profound failure of cell growth (addition
of size and mass), and a secondary failure of proliferation; (2)
TRPM7-deficient cells cultured in regular media exhibit sub-
stantially decreased signaling along the entire phosphoinositide
3-kinase/Akt/mTOR/S6K protein-translation regulatory path-
way; and (3) heterologous expression of a membrane-targeted,
constitutively active p110 phosphoinositide 3-kinase comple-
ments phosphoinositide 3-kinase signaling, cell growth, and
proliferation of TRPM7-deficient cells grown in regular media.
Overall, these results suggest that a central function of TRPM7
is to promote sustained activation of cellular phosphoinositide
3-kinase signals, thus positioning TRPM7 alongside phosphoi-
nositide 3-kinases as a central regulator of vertebrate lympho-
cyte growth.
A significant question raised by our results is the nature of the
mechanism through which TRPM7 is influencing phosphoinosi-
tide 3-kinase-dependent signaling. The fact that supplemental
Mg2+ is able to support growth of TRPM7-deficient cells argues
that this mechanism somehow involves Mg2+ ions entering the
cell. While evidence supporting changes in global free Mg2+ as
a signaling phenomena has been reported (reviewed in Takaya
et al., 2000), we could not detect global population changes
in intracellular free Mg2+ (Figure S4). However, physiologically
relevant changes in free Mg2+ may potentially occur within mi-
crodomains surrounding Mg2+ transporters. Understanding
how Mg2+ entering via TRPM7 and other Mg2+ transporters influ-
ences sustained phosphoinositide 3-kinase signaling promises
to yield new insights into the links between metabolism and
growth regulation in lymphocytes as well as other cell types.
A final intriguing implication of our results is that there is close
linkage between Mg2+ uptake and biosynthetic metabolismCell Metabolism 8, 84–93, July 2008 ª2008 Elsevier Inc. 89
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TRPM7 Supports Sustained PI3K Signalingrequired for cell growth. Why might such a link exist? A compel-
ling explanation lies in the different requirements for cell metab-
olism in quiescent versus dividing cells. While both quiescent
and dividing cells require glucose to satisfy their energy de-
mands, quiescent cells utilize glucose to recycle existing MgADP
to MgATP (both ATP and ADP exist primarily in their Mg2+-bound
forms). As Mg2+ is not lost in the process of mitochondrial ATP
regeneration, no new Mg2+ ions are required to support this
form of energy production. In contrast, a cell progressing
through the cell cycle utilizes glycolysis and the pentose-phos-
phate shunt to generate substrates for addition of cell mass (re-
viewed in Frauwirth and Thompson, 2004), and in lymphocytes,
rapid bursts of growth are accompanied by the largely de novo
synthesis of an expanded cellular pool of ATP for apportioning
between its daughters (Allison et al., 1977). As each newly syn-
thesized ATP molecule requires a new Mg2+ ion be imported
from the extracellular milieu, closely linking Mg2+ uptake and bio-
synthetic metabolism is an attractively simple mechanism to al-
low cells to switch between quiescent and proliferative meta-
bolic states: in the former situation, Mg2+ uptake is limited,
switching off growth pathways and focusing cellular carbon
flux on (Mg2+) ATP regeneration; in contrast, in the latter situa-
tion, Mg2+ uptake is active, switching on growth pathways and
focusing cellular carbon flux on synthesis of new biomolecules,
including new molecules of (Mg2+) ATP.
EXPERIMENTAL PROCEDURES
Materials
The phospho-p70 S6Kinase (S6K1) (Thr389), phospho-Akt (Ser473 and
Thr308), phospho-4E-BP1 (Ser65), phospho-p44/42 MAP kinase (Thr202/
Tyr204), p70S6kinase, Akt, 4E-BP1, Erk, HA-tag, and PI3 kinase p110a anti-
bodies were obtained from Cell Signaling Technology. Rapamycin (mTOR in-
hibitor), wortmannin (PI3K inhibitor), and DAPI were purchased from Sigma.
The cDNA encoding myr-Akt (D4-129, HA-tagged at C terminus) was a kind
gift from Dr. Ann Olson/Dr. Morris Birnbaum and has been previously de-
scribed (Kohn et al., 1996). The cDNA encoding for His-tagged myr-p110a
was obtained from Addgene (Addgene plasmid 10836, Auger et al., 2000).DT40 Cell-Line Construction and Culture
DT40 cells were maintained in Roswell Park Memorial Institute (RPMI 1640)
(Mediatech) with 10% fetal bovine serum (FBS), 1% chicken serum, 10 U/ml
penicillin/streptomycin, 2 mM glutamine, and 50 mg/ml blasticidin. Construc-
tion of the TRPM7-KO cell line in a DT40 parental cell line expressing the
tetracycline transcriptional suppressor using pCDNA6/TR (Invitrogen) and
complementation of its growth with MgCl2 has been previously described
(Schmitz et al., 2003).
Cell Size and Cell-Cycle Analyses
DNA content and cell-cycle analyses were carried out after fixation of cells and
staining them with DAPI. Cells were acquired on LSRII flow cytometer (BD Bio-
sciences) and analyzed by Flowjo (Ashland, Oregon). Briefly, 1–2 3 106 cells
were spun and washed once with PBS. Cells were then fixed by adding 1 ml
of ice-cold 70% ethanol and were stored at 4C for at least 1 hr, followed by
two washes with PBS. DAPI (1 mg/ml) dissolved in PBS, 0.1% BSA, and
0.1% Triton X-100 was added to the cells and mixed well. Cells were kept at
4C for 30 min and analyzed on the LSRII flow cytometer (BD Biosciences)
with ultraviolet excitation and DAPI emission collected at >450 nm. Percent-
ages of cells existing within the various phases of the cell cycle were calculated
by gating on G0, G1, S, and G2/M cell populations visualized using the cell-
cycle platform in FlowJo. Forward scatter (FSC) was used to quantify the
cell size.
Establishment of an Optimal Time Frame
for Phosphorylation Analysis
For analysis of cells under growth-supporting and growth-arresting condi-
tions, DT40 WT cells (used as a control) were washed twice with PBS and
resuspended in fresh RPMI media for 2 hr at 37C prior to starting the exper-
iment so as to allow signaling induced by exposure to nutrients and growth fac-
tors to decay to basal levels. The cells were then counted and divided into
three groups: (1) cells in regular RPMI without any supplemental Mg2+, (2) cells
in regular RPMI with 15 mM supplemental Mg2+, and (3) cells in regular RPMI
with 15 mM supplemental Mg2+ and 100 nM rapamycin/insulin/wortmannin
depending on the experiment being conducted. TRPM7-KO cells, which
grow only in the presence of 10–15mM supplemental Mg2+, were treated in
a slightly different manner. While investigating for an optimal time frame,
TRPM7-KO cells were washed twice with PBS and transferred to fresh
RPMI either with or without supplemental Mg2+ and analyzed for S6K1 phos-
phorylation from 1 to 5 hr, respectively. A sizeable increase in S6K1 phosphor-
ylation was observed as early as 0.5–1 hr after transfer to regular as well as
growth-supporting media (containing supplemental Mg2+) as can be seen inFigure 4. Heterologous Sustained PI3K Signaling Complements Growth and Growth Regulatory Signaling Failures of TRPM7-Deficient Cells
in Regular Media
(A) Sustained PI3K signaling is required for sustained Akt activation in TRPM7-deficient cells expressing doxycycline-inducible myr-p110a. Left panel: western
immunoblotting analysis of a TRPM7-KO clone with inducible expression of a 6X-His-tagged myristoylated form of p110a is shown. Right panel: western immu-
noblotting analysis of Akt activation in the presence and absence of 48 hr doxycycline induction, followed by 5 hr culture in regular media, and either continued
culture in that media () or addition of 15 mM supplemental Mg2+ (+) for the indicated times, is shown. Myr-p110a expression produces enhanced sustained
activation of the PI3K effector Akt, albeit to levels slightly less than those observed in Mg2+-supplemented media (+).
(B) Heterologous sustained PI3K signals complements the cell-cycle arrest and cell-size reduction, both of which occur when TRPM7-deficient cells are transi-
tioned to regular media. Left panel: DAPI DNA-content analysis of TRPM7-deficient cells in the indicated conditions, demonstrating that induction of myr-p110a
expression allows exit of TRPM7-deficient cells from G0/G1 arrest, is shown. Right panel: flow cytometric analysis of the cell size of WT, myr-p110 expressing
TRPM7-deficient cells cultured in regular media (), or myr-p110-expressing cells cultured in Mg2+ supplemented media (+), is shown. While TRPM7-deficient
cells normally are substantially smaller than WT DT40, myr-p110 expression restores their size to the equivalent of DT40 cells when cultured in regular media, and
to supranormal size when cultured with supplemental Mg2+.
(C) Prolonged growth of TRPM7-deficient cells expressing constitutively active mp110-PI3K results in selection of cells with enhanced mp110-PI3K expression
and cell-cycle complementation. Left panel: western immunoblotting analysis of myr-p110a expression in TRPM7-deficient cells induced in Mg2+-supplemented
media (48 hr induction), and after 18 days of induction and culture in regular media followed by the indicated number of days without doxycycline, is shown. Right
panel: DAPI DNA-content analysis of cell-cycle distribution of myr-p110-expressing cells cultured in regular media () with doxycycline added/withdrawn for the
indicated periods of time is shown.
(D) mp110-PI3K expression provides sustained growth regulatory signaling to TRPM7-deficient cells. Left panel: western immunoblotting analysis of Akt Ser473
phosphorylation after 3 weeks of induction of myr-p110a expression is shown. myr-p110-expressing TRPM7-deficient cells were cultured in regular media for
5 hr, and then continued in that media (), or supplemental Mg2+ was added (+). A high level of myr-p110a expression in these cells produces fully sustained
activation of the PI3K effector Akt, which is wortmannin sensitive. Right panel: western immunoblotting analysis of S6K1 Thr389 phosphorylation after 3 weeks
of induction of myr-p110 is shown. Myr-p110-expressing TRPM7-deficient cells were cultured in regular media for 5 hr, and then continued in that media ()
or supplemental Mg2+ was added (+). A high level of myr-p110a expression in these cells produces nearly fully sustained activation of the S6K1 translational
regulator, which is wortmannin sensitive. All data are representative of at least two independent sets of experiments.Cell Metabolism 8, 84–93, July 2008 ª2008 Elsevier Inc. 91
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TRPM7 Supports Sustained PI3K SignalingFigure S1, left panel. To establish an approximate time point of downregulation
of S6K1 phosphorylation, TRPM7-KO cells were washed twice with PBS and
transferred to fresh media with 15 mM [Mg2+]ex for 2 hr. Subsequently, the cells
were washed with PBS twice and transferred to fresh RPMI either with or with-
out supplemental Mg2+ and analyzed for S6K1 phosphorylation until 8 hr. A de-
tectable decrease in phosphorylation of S6K1 was observed starting from 3 hr
posttransfer of TRPM7-deficient cells from growth-supporting to regular me-
dia, and was substantially downregulated by 5 hr posttransfer, indicating
that TRPM7-KO cells are able to sense and respond to Mg2+ limitation within
a time frame of 5 hr with minimal side effects (Figure 2A, upper-left panel). For
further experiments, TRPM7-KO cells were washed twice with PBS and resus-
pended in fresh RPMI media without supplemental Mg2+ for 5 hr at 37C prior
to starting the experiment. The cells were counted and divided into three
groups with a similar approach as for WT DT40 cells, harvested at various
time points, and stored at 80C until further analysis after washing with PBS.
Whole Cell-Lysate Preparation, Electrophoresis,
and Western Blotting
After treatments, cells were washed once with PBS and whole cell lysates were
prepared by lysing the cells in ice-cold lysis buffer (20 mM Tris-HCl [pH 7.4],
120 mM NaCl, 20 mM NaF, 1mM EDTA, 6 mM EGTA, 20 mM b-glycerophos-
phate, 0.5 mM DTT, 1 mM sodium vanadate [Na3VO4], 1% NP-40) and com-
plete mini-protease-inhibitor cocktail without EDTA (Roche), used according
to manufacturer’s instructions. The lysates were rotated for 45 min at 4C,
and cell debris was removed by centrifugation at 14,000 rpm for 15 min at
4C. Protein concentration of the lysates was determined either by Bradford
Protein Assay (Bio-Rad) or Bicinchoninic acid (BCA; Pierce) using the manu-
facturer’s specifications. Gels were loaded with 50–60 mg of protein/sample
per lane. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) was carried out according to the method of Laemmli. Aliquots of the
supernatant were separated on SDS-PAGE gels (15% for 4E-BP1, 10% for
Akt, S6K1, and Erk, and 8% for p110a) and were analyzed by immunoblotting
(IB). The proteins were transferred to 0.45 mm pore size PVDF membranes (pol-
yvinylidene fluoride; Millipore) in transfer buffer (39 mM glycine, 48 mM tris
base, and 20% methanol) at 300 mA for 1–2 hours at 4C. Membranes were
blocked in 5% blocking buffer (5% w/v nonfat dry milk in TBS-0.1% Tween-
20) for 1 hr at room temperature. Primary-antibody incubations were done
overnight at the dilutions specified by the vendor. Incubations with the second-
ary antibody were performed with peroxidase-coupled anti-rabbit/anti-mouse
immunoglobulin in 5% blocking buffer and the bound antibody was detected
by the ECL Chemiluminescence Detection System (Amersham). For p-S6K1
quantitation, western blots from three independent experiments were
scanned, and the specific p-S6K1 bands were densitometrically quantitated
with Adobe Photoshop CS software (Adobe Systems, San Jose´, CA). Band
densities were corrected for background using a reference area close to
each band, and p-S6K1 band intensities were normalized for loading by nor-
malization to the total S6K1 band intensity obtained by stripping and reprobing
the same blot. P values for the fold change were determined using a one-tailed
Student’s t test assuming equal variances.
Myristoylated Akt (myr-Akt) and myr-p110 PI3K Cloning
and Expression
Myr-Akt comprises murine Akt-1 with the src myristoylation sequence fused to
the N terminus and hemagglutinin (HA) tag at the C terminus. Myr-Akt was
cloned into pcDNA5/TO vector (Invitrogen, T-REx System), which provides
a tetracycline-controlled expression from a cytomegalovirus (CMV) immediate
early promoter and its expression was induced by overnight treatment with
1 mg/ml doxycycline. The pcDNA5/TO-myrAkt-HA construct was transfected
by electroporation into TRPM7-KO DT40 cells expressing the tet repressor
protein (via previous stable transfection with pCDNA6/TR). Electroporation
was carried out at 550V/25 mF in 4 mm electroporation cuvettes (BioRad
Gene Pulser Xcell), and the cuvettes were placed on ice for 5 min before
and after pulsing. Cells were cultured in RPMI-1640 media supplemented
with 10% FBS, 1% chicken serum, 10 U/ml penicillin/streptomycin, and
2 mM glutamine overnight, prior to plating them into 96-well plates at various
dilutions, under antibiotic selection along with addition of 15 mM Mg2+ for
TRPM7-KO cells. The resistant clones were selected with hygromycin
(2 mg/ml; Calbiochem) for myr-Akt-HA transfection and were analyzed for92 Cell Metabolism 8, 84–93, July 2008 ª2008 Elsevier Inc.doxycycline-induced protein expression by western blotting with the anti-
HA antibody. Its phosphorylation status was further confirmed with the phos-
pho-Akt S473 antibody. The myr-p110a-His expression construct was made
by cloning myr-p110a-His into pcDNA5/TO followed by transfection into
TRPM7-KO cells. The resistant clones were selected and analyzed for protein
expression by immunoprecipitation with Ni2+-NTA agarose according to
a specified protocol. Further PI3K modulation studies were carried out in pres-
ence/absence of 15 mM Mg2+.
Measurement of Intracellular Mg2+
DT40 WT and TRPM7-KO cells were harvested at the indicated time points,
washed twice with PBS, and resuspended in fresh RPMI or were kept in the
original media in which they had been growing. Cells were then labeled with
mag-indo-1 (Molecular Probes, Eugene, OR), dissolved in dimethyl sulphoxide
(DMSO, Fisher), and incubated for 35 min at 37C under 5% CO2. After wash-
ing twice with PBS, cells were resuspended either in HBSS without Ca2+ and
Mg2+ and 2% FCS or in regular RPMI. Blue/violet fluorescence data were col-
lected on the LSR II flow cytometer at room temperature. Data were subse-
quently analyzed offline using Flowjo (Ashland, OR).
SUPPLEMENTAL DATA
Supplemental Data include four figures and can be found online at http://www.
cellmetabolism.org/cgi/content/full/8/1/84/DC1/.
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